Use of Screening Dried Blood Spots for Estimation of Prevalence, Risk Factors, and Birth Outcomes of Congenital Cytomegalovirus Infection
To access this article, please choose from the options below
Funded by the National Vaccine Program Office of the Centers for Disease Control and Prevention via a contract with the Sequoia Foundation. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The authors declare no conflicts of interest.
PII: S0022-3476(10)00216-7
doi:10.1016/j.jpeds.2010.03.002
© 2010 Mosby, Inc. All rights reserved.
Refers to article:
- Congenital Cytomegalovirus Infection: Screening and Treatment , 14 June 2010
- Is a 6-Week Course of Ganciclovir Therapy Effective for Chorioretinitis in Infants with Congenital Cytomegalovirus Infection? , 19 April 2010
